Form 4 for IBRX ImmunityBio, Inc.
Accepted 2023-06-05 00:00:00 ET · period of report 2023-06-05 · accession 0001326110-23-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-06-05 | 2023-06-05 | IBRX | BLASZYK MICHAEL D | Dir | P - Purchase | $2.75 | +71.9K | 71.9K | New | +$198.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-05 | P | A | 48,000 | $2.77 | 71,430 | I By trust | — | — | |
| 2 | Common | Common Stock | 2023-06-05 | P | A | 23,430 | $2.72 | 23,430 | I By trust | — | — | |
| 3 | Common | Common Stock | 2023-06-05 | P | A | 485 | $2.75 | 71,915 | I By trust | — | — |